This company has been acquired
Home Capital Group Future Growth
Future criteria checks 1/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Home Capital Group.
Key information
n/a
Earnings growth rate
20.8%
EPS growth rate
Diversified Financial earnings growth | 60.4% |
Revenue growth rate | 12.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 31 Aug 2023 |
Recent future growth updates
Recent updates
Here's Why We Think Home Capital Group (TSE:HCG) Might Deserve Your Attention Today
Jul 15Need To Know: Analysts Just Made A Substantial Cut To Their Home Capital Group Inc. (TSE:HCG) Estimates
May 07Do Home Capital Group's (TSE:HCG) Earnings Warrant Your Attention?
Apr 07With EPS Growth And More, Home Capital Group (TSE:HCG) Is Interesting
Dec 07With EPS Growth And More, Home Capital Group (TSE:HCG) Is Interesting
Sep 08The Compensation For Home Capital Group Inc.'s (TSE:HCG) CEO Looks Deserved And Here's Why
May 12With EPS Growth And More, Home Capital Group (TSE:HCG) Is Interesting
May 09Did Home Capital Group Inc. (TSE:HCG) Insiders Buy Up More Shares?
Mar 16Did You Miss Home Capital Group's (TSE:HCG) 96% Share Price Gain?
Feb 18With EPS Growth And More, Home Capital Group (TSE:HCG) Is Interesting
Jan 23What Type Of Shareholders Make Up Home Capital Group Inc.'s (TSE:HCG) Share Registry?
Dec 28Are Insiders Buying Home Capital Group Inc. (TSE:HCG) Stock?
Dec 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 619 | 261 | N/A | N/A | 1 |
12/31/2023 | 555 | N/A | N/A | N/A | 1 |
6/30/2023 | 513 | 174 | -696 | -683 | N/A |
3/31/2023 | 483 | 157 | -1,536 | -1,522 | N/A |
12/31/2022 | 472 | 150 | -1,741 | -1,726 | N/A |
9/30/2022 | 490 | 170 | -1,181 | -1,163 | N/A |
6/30/2022 | 516 | 193 | -1,191 | -1,175 | N/A |
3/31/2022 | 557 | 225 | -159 | -141 | N/A |
12/31/2021 | 583 | 245 | 275 | 293 | N/A |
9/30/2021 | 597 | 247 | 89 | 109 | N/A |
6/30/2021 | 601 | 251 | 382 | 411 | N/A |
3/31/2021 | 557 | 212 | -252 | -222 | N/A |
12/31/2020 | 502 | 176 | -70 | -40 | N/A |
9/30/2020 | 474 | 158 | -318 | -293 | N/A |
6/30/2020 | 443 | 138 | -155 | -135 | N/A |
3/31/2020 | 435 | 136 | 107 | 126 | N/A |
12/31/2019 | 436 | 136 | -749 | -733 | N/A |
9/30/2019 | 420 | 135 | -967 | -953 | N/A |
6/30/2019 | 408 | 128 | -1,570 | -1,558 | N/A |
3/31/2019 | 398 | 126 | -1,423 | -1,415 | N/A |
12/31/2018 | 398 | 133 | -1,118 | -1,111 | N/A |
9/30/2018 | 400 | 127 | -497 | -489 | N/A |
6/30/2018 | 399 | 125 | 658 | 666 | N/A |
3/31/2018 | 240 | -16 | 3,586 | 3,596 | N/A |
12/31/2017 | 284 | 8 | 3,524 | 3,535 | N/A |
9/30/2017 | 320 | 28 | 3,313 | 3,327 | N/A |
6/30/2017 | 364 | 64 | 2,598 | 2,614 | N/A |
3/31/2017 | 572 | 241 | N/A | -172 | N/A |
12/31/2016 | 573 | 247 | N/A | 341 | N/A |
9/30/2016 | 579 | 267 | N/A | 331 | N/A |
6/30/2016 | 577 | 273 | N/A | 77 | N/A |
3/31/2016 | 577 | 279 | N/A | -249 | N/A |
12/31/2015 | 574 | 287 | N/A | -820 | N/A |
9/30/2015 | 596 | 313 | N/A | -819 | N/A |
6/30/2015 | 593 | 314 | N/A | -1,299 | N/A |
3/31/2015 | 588 | 316 | N/A | -1,688 | N/A |
12/31/2014 | 580 | 313 | N/A | -1,313 | N/A |
9/30/2014 | 539 | 286 | N/A | -2,159 | N/A |
6/30/2014 | 523 | 279 | N/A | -2,048 | N/A |
3/31/2014 | 499 | 267 | N/A | -1,920 | N/A |
12/31/2013 | 481 | 257 | N/A | -2,117 | N/A |
9/30/2013 | 463 | 247 | N/A | -1,604 | N/A |
6/30/2013 | 448 | 238 | N/A | -1,587 | N/A |
3/31/2013 | 438 | 229 | N/A | -2,187 | N/A |
12/31/2012 | 423 | 222 | N/A | -2,382 | N/A |
9/30/2012 | 407 | 213 | N/A | -2,377 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if HCG's forecast earnings growth is above the savings rate (1.9%).
Earnings vs Market: Insufficient data to determine if HCG's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if HCG's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HCG's revenue (12.4% per year) is forecast to grow faster than the Canadian market (6.1% per year).
High Growth Revenue: HCG's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HCG's Return on Equity is forecast to be high in 3 years time